Skip to main content Accessibility help
×
Home

Levodopa and executive performance in Parkinson's disease: A randomized study

  • BERTA PASCUAL-SEDANO (a1), JAIME KULISEVSKY (a1), MANEL BARBANOJ (a2), CARMEN GARCÍA-SÁNCHEZ (a3), ANTONIA CAMPOLONGO (a1), ALEXANDRE GIRONELL (a1), JAVIER PAGONABARRAGA (a1) and IGNASI GICH (a4)...

Abstract

Parkinson's disease (PD) patients may experience fluctuations in executive performance after oral levodopa (LD). Their relationship with the pharmacokinetic profile of LD and with distinct cognitive processes associated with frontal-basal ganglia circuits is not well understood. In this randomized, double-blind, crossover study we plotted acute cognitive changes in 14 PD patients challenged with faster (immediate-release, IR) versus slower (controlled-release, CR) increases in LD plasma concentrations. We monitored motor status, LD plasma levels, and performance on four tasks of executive function (Wisconsin Card Sorting Test—WCST, Sternberg test, Stroop and Tower of Hanoi), 1 hr before and over +6 hr after IR and CR-LD dose. Analysis of variance demonstrated significant but divergent changes in the Sternberg (6-digit but not 2- and 4-digit) test: improvement after CR-LD and worsening after IR-LD. Marginal improvement (p = .085) was observed with CR-LD in the WCST, while no significant differences were seen for the Stroop or Tower of Hanoi tests. Executive-related performance after LD challenge may differ depending on the LD time-to-peak plasma concentration and specific task demands. A slower rise in LD levels appears to have a more favorable impact on more difficult working memory tests. These results require replication to determine their generalization. (JINS, 2008, 14, 832–841.)

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Levodopa and executive performance in Parkinson's disease: A randomized study
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Levodopa and executive performance in Parkinson's disease: A randomized study
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Levodopa and executive performance in Parkinson's disease: A randomized study
      Available formats
      ×

Copyright

Corresponding author

Correspondence and reprint request to: Jaime Kulisevsky, Neurology Department (Movement Disorders Unit), Hospital de la Santa Creu i Sant Pau. Calle Sant Antoni M. Claret, 167, 08025 Barcelona, Spain. E-mail: jkulisevsky@santpau.cat

References

Hide All
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4thed.). Washington, DC: American Psychiatric Association.
Bäckman, L., Ginovart, N., Dixon, R.A., Wahlin, T.B., Wahlin, A., Halldin, C., & Farde, L. (2000). Age-related cognitive deficits mediated by changes in the striatal dopamine system. The American Journal of Psychiatry, 157, 635637.
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561571.
Bejjani, B.P., Arnulf, I., Demeret, S., Damier, P., Bonnet, A.M., Houeto, J.L., & Agid, Y. (2000). Levodopa-induced dyskinesias in Parkinson's disease: Is sensitization reversible? Annals of Neurology, 47, 655658.
Brown, R.G. & Marsden, C.D. (1990). Cognitive function in Parkinson's disease: From description to theory. Trends in Neuroscience, 13, 2129.
Chase, T.N. & Oh, J.D. (2000). Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends in Neuroscience, 23, S86S91.
Cools, R. (2006). Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neuroscience and Biobehavioral Reviews, 30, 123.
Cools, R., Barker, R.A., Sahakian, B.J., & Robbins, T.W. (2001). Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex, 11, 11361143.
Cools, R., Barker, R.A., Sahakian, B.J., & Robbins, T.W. (2003). L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia, 41, 14311441.
Cools, R., Stefanova, E., Barker, R.A., Robbins, T.W., & Owen, A.M. (2002). Dopaminergic modulation of high-level cognition in Parkinson's disease: The role of the prefrontal cortex revealed by PET. Brain, 125, 584594.
Costa, A., Peppe, A., Dell'Agnello, G., Carlesimo, G.A., Murri, L., Bonuccelli, U., & Caltagirone, C. (2003). Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. Dementia and Geriatric Cognitive Disorders, 15, 5566.
Cropley, V.L., Fujita, M., Innis, R.B., & Nathan, P.J. (2006). Molecular imaging of the dopaminergic system and its association with human cognitive function. Biological Psychiatry, 59, 898907.
Dagher, A., Owen, A.M., Boecker, H., & Brooks, D.J. (2001). The role of the striatum and hippocampus in planning: A PET activation study in Parkinson's disease. Brain, 124, 10201032.
Damier, P., Hirsch, E.C., Agid, Y., & Graybiel, A.M. (1999). The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain, 122(Pt. 8), 14371448.
de la Fuente-Fernández, R., Lu, J.Q., Sossi, V., Jivan, S., Schulzer, M., Holden, J.E., Lee, C.S., Ruth, T.J., Calne, D.B., & Stoessl, A.J. (2001). Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. Annals of Neurology, 49, 298303.
de la Fuente-Fernández, R., Sossi, V., Huang, Z., Furtado, S., Lu, J.Q., Calne, D.B., Ruth, T.J., & Stoessl, A.J. (2004). Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias. Brain, 127, 27472754.
Dreher, J.C., Guigon, E., & Burnod, Y. (2002). A model of prefrontal cortex dopaminergic modulation during the delayed alternation task. Journal of Cognitive Neuroscience, 14, 853865.
Egner, T. & Hirsch, J. (2005). The neural correlates and functional integration of cognitive control in a Stroop task. Neuroimage, 24, 539547.
El-Ghundi, M., O'Dowd, B.F., & George, S.R. (2007). Insights into the role of dopamine receptor systems in learning and memory. Reviews in the Neurosciences, 18, 3766.
Emre, M. (2003). What causes mental dysfunction in Parkinson's disease? Movement Disorders, 18(Suppl. 6), S63S71.
Fahn, S. (2006). Levodopa in the treatment of Parkinson's disease. Journal of Neural Transmission Supplementum, 115.
Fera, F., Nicoletti, G., Cerasa, A., Romeo, N., Gallo, O., Gioia, M.C., Arabia, G., Pugliese, P., Zappia, M., & Quattrone, A. (2007). Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease. Brain Research Bulletin, 74, 7583.
First, M. (1995). Structured Clinical Interview for DSM-IV Axis Disorders, Patient Edition (SCID-P), Version 2. New York: New York State Psychiatric Institute, Biometrics Research.
Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research, 12, 189198.
Fournet, N., Moreaud, O., Roulin, J.L., Naegele, B., & Pellat, J. (2000). Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication. Neuropsychology, 14, 247253.
Frank, M.J., Seeberger, L.C., & O'Reilly, R.C. (2004). By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science, 306, 19401943.
Golden, C.J. (1978). Stroop Color and Word Test. Chicago, IL: Stoelting Co.
Goldman-Rakic, P.S., Muly, E.C. III., & Williams, G.V. (2000). D(1) receptors in prefrontal cells and circuits. Brain Research. Brain Research Reviews, 31, 295301.
Gotham, A.M., Brown, R.G., & Marsden, C.D. (1988). ‘Frontal’ cognitive function in patients with Parkinson's disease ‘on’ and ‘off’ levodopa. Brain, 111(Pt. 2), 299321.
Grossman, M., Glosser, G., Kalmanson, J., Morris, J., Stern, M.B., & Hurtig, H.I. (2001). Dopamine supports sentence comprehension in Parkinson's Disease. Journal of the Neurological Sciences, 184, 123130.
Heaton, R.K., Chelune, G.I., Talley, L.L., Kay, G.G., & Curtis, G. (1993). Wisconsin Card Sorting Test (WCST). Manual Revised and Expanded. Odessa, FL: Psychological Assessment Resources.
Hughes, A.J., Daniel, S.E., Kilford, L., & Lees, A.J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery, and Psychiatry, 55, 181184.
Janvin, C., Aarsland, D., Larsen, J.P., & Hugdahl, K. (2003). Neuropsychological profile of patients with Parkinson's disease without dementia. Dementia and Geriatric Cognitive Disorders, 15, 126131.
Jellinger, K. (1987). Neuropathological substrates of Alzheimer's disease and Parkinson's disease. Journal of Neural Transmission. Supplementum, 24, 109129.
Jellinger, K.A. (2001). The pathology of Parkinson's disease. Advances in Neurology, 86, 5572.
Kish, S.J., Shannak, K., & Hornykiewicz, O. (1988). Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. The New England Journal of Medicine, 318, 876880.
Kosmidis, M.H., Bozikas, V.P., Zafiri, M., & Karavatos, A. (2006). Shared cognitive processes underlying performance on the Wisconsin Card Sorting Test and the Stroop Test in patients with schizophrenia: A measurement artifact? Neuroscience Letters, 409, 234238.
Kulisevsky, J. (2000). Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs & Aging, 16, 365379.
Kulisevsky, J., Avila, A., Barbanoj, M., Antonijoan, R., Berthier, M.L., & Gironell, A. (1996). Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain, 119(Pt 6), 21212132.
Lange, K.W., Robbins, T.W., Marsden, C.D., James, M., Owen, A.M., & Paul, G.M. (1992). L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl), 107, 394404.
Lees, A.J. & Smith, E. (1983). Cognitive deficits in the early stages of Parkinson's disease. Brain, 106(Pt 2), 257270.
Malapani, C., Pillon, B., Dubois, B., & Agid, Y. (1994). Impaired simultaneous cognitive task performance in Parkinson's disease: A dopamine-related dysfunction. Neurology, 44, 319326.
Malapani, C., Rakitin, B., Levy, R., Meck, W.H., Deweer, B., Dubois, B., & Gibbon, J. (1998). Coupled temporal memories in Parkinson's disease: A dopamine-related dysfunction. Journal of Cognitive Neuroscience, 10, 316331.
Mattay, V.S., Tessitore, A., Callicott, J.H., Bertolino, A., Goldberg, T.E., Chase, T.N., Hyde, T.M., & Weinberger, D.R. (2002). Dopaminergic modulation of cortical function in patients with Parkinson's disease. Annals of Neurology, 51, 156164.
McCaffrey, R.J. & Westervelt, H.J. (1995). Issues associated with repeated neuropsychological assessments. Neuropsychology Review, 5, 203221.
McCormack, H.M., Horne, D.J., & Sheather, S. (1988). Clinical applications of visual analogue scales: A critical review. Psychological Medicine, 18, 10071019.
Mizoguchi, K., Yuzurihara, M., Ishige, A., Sasaki, H., Chui, D.H., & Tabira, T. (2000). Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. The Journal of Neuroscience, 20, 15681574.
Mollion, H., Ventre-Dominey, J., Dominey, P.F., & Broussolle, E. (2003). Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease. Neuropsychologia, 41, 14421451.
Monchi, O., Petrides, M., Doyon, J., Postuma, R.B., Worsley, K., & Dagher, A. (2004). Neural bases of set-shifting deficits in Parkinson's disease. The Journal of Neuroscience, 24, 702710.
Mouradian, M.M., Heuser, I.J., Baronti, F., Fabbrini, G., Juncos, J.L., & Chase, T.N. (1989). Pathogenesis of dyskinesias in Parkinson's disease. Annals of Neurology, 25, 523526.
Nutt, J.G. (2007). Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa? Movement Disorders, 22, 19.
Nutt, J.G. & Holford, N.H. (1996). The response to levodopa in Parkinson's disease: Imposing pharmacological law and order. Annals of Neurology, 39, 561573.
Oh, J.D., Geller, A.I., Zhang, G., & Chase, T.N. (2003). Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats. Brain Research, 971, 1830.
Olanow, C.W., Agid, Y., Mizuno, Y., Albanese, A., Bonuccelli, U., Damier, P., De Yebenes, J., Gershanik, O., Guttman, M., Grandas, F., Hallett, M., Hornykiewicz, O., Jenner, P., Katzenschlager, R., Langston, W.J., LeWitt, P., Melamed, E., Mena, M.A., Michel, P.P., Mytilineou, C., Obeso, J.A., Poewe, W., Quinn, N., Raisman-Vozari, R., Rajput, A.H., Rascol, O., Sampaio, C., & Stocchi, F. (2004). Levodopa in the treatment of Parkinson's disease: Current controversies. Movement Disorders, 19, 9971005.
Peavy, G.M., Salmon, D., Bear, P.I., Paulsen, J.S., Cahn, D.A., Hofstetter, C.R., Kaplan, E.F., Delis, D.C., & Shult, C.W. (2001). Detection of mild cognitive deficits in Parkinson's disease patients with the WAIS-R NI. Journal of the International Neuropsychological Society, 7, 535543.
Poewe, W., Berger, W., Benke, T., & Schelosky, L. (1991). High-speed memory scanning in Parkinson's disease: Adverse effects of levodopa. Annals of Neurology, 29, 670673.
Rodriguez-Oroz, M.C., Obeso, J.A., Lang, A.E., Houeto, J.L., Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M.I., Quinn, N.P., Speelman, J.D., Guridi, J., Zamarbide, I., Gironell, A., Molet, J., Pascual-Sedano, B., Pidoux, B., Bonnet, A.M., Agid, Y., Xie, J., Benabid, A.L., Lozano, A.M., Saint-Cyr, J., Romito, L., Contarino, M.F., Scerrati, M., Fraix, V., & Van Blercom, N. (2005). Bilateral deep brain stimulation in Parkinson's disease: A multicentre study with 4 years follow-up. Brain, 128(Pt. 10), 22402249.
Schrag, A., Jahanshahi, M., & Quinn, N. (2000). What contributes to quality of life in patients with Parkinson's disease? Journal of Neurology, Neurosurgery, and Psychiatry, 69, 308312.
Schroeder, U., Kuehler, A., Haslinger, B., Erhard, P., Fogel, W., Tronnier, V.M., Lange, K.W., Boecker, H., & Ceballos-Baumann, A.O. (2002). Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: A PET study. Brain, 125(Pt. 9), 19952004.
Shohamy, D., Myers, C.E., Geghman, K.D., Sage, J., & Gluck, M.A. (2006). L-dopa impairs learning, but spares generalization, in Parkinson's disease. Neuropsychologia, 44, 774784.
Simon, H.A. (1975). The functional equivalence of problem solving skills. Cognitive Psychology, 7, 268288.
Skeel, R.L., Crosson, B., Nadeau, S.E., Algina, J., Bauer, R.M., & Fennell, E.B. (2001). Basal ganglia dysfunction, working memory, and sentence comprehension in patients with Parkinson's disease. Neuropsychologia, 39, 962971.
Sternberg, S. (1966). High-speed scanning in human memory. Science, 153, 652654.
Swainson, R., Rogers, R.D., Sahakian, B.J., Summers, B.A., Polkey, C.E., & Robbins, T.W. (2000). Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: Possible adverse effects of dopaminergic medication. Neuropsychologia, 38, 596612.
Taylor, A.E., Saint-Cyr, J.A., & Lang, A.E. (1986). Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain, 109(Pt. 5), 845883.
Vijayraghavan, S., Wang, M., Birnbaum, S.G., Williams, G.V., & Arnsten, A.F. (2007). Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nature Neuroscience, 10, 376384.
Volkow, N.D., Gur, R.C., Wang, G.J., Fowler, J.S., Moberg, P.J., Ding, Y.S., Hitzemann, R., Smith, G., & Logan, J. (1998). Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. The American Journal of Psychiatry, 155, 344349.
Westin, J.E., Andersson, M., Lundblad, M., & Cenci, M.A. (2001). Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease. The European Journal of Neuroscience, 14, 11711176.
Williams, G.V. & Goldman-Rakic, P.S. (1995). Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature, 376, 572575.
Witjas, T., Kaphan, E., Azulay, J.P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A.A. (2002). Nonmotor fluctuations in Parkinson's disease: Frequent and disabling. Neurology, 59, 408413.
Yeh, K.C., August, T.F., Bush, D.F., Lasseter, K.C., Musson, D.G., Schwartz, S., Smith, M.E., Titus, D.C. (1989). Pharmacokinetics and bioavailability of Sinemet CR: A summary of human studies. Neurology, 39 (Suppl. 2), 2538.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed